- Reversal of Immunogenicity in Pediatric Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Medications
-
Kang E, Khalili A, Splawski J, Sferra TJ, Moses J
- KMID: 2421996
- Pediatr Gastroenterol Hepatol Nutr.
- 2018 Oct;21(4):329-335.
- doi: 10.5223/pghn.2018.21.4.329
Loss of response to anti-tumor necrosis factor (anti-TNF) agents in the treatment of inflammatory bowel disease (IBD) is a major consideration to maintain sustained response. Reversal of immunogenicity can re-establish... -
- CITED
-
- Close
- SHARE
-
- Close
